Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Analysis of Next Generation Sequencing Data for Rare Variant Burden in Parkinson's Disease and Per-Domain Study of Parkinson's Risk Genes

FY 2023-24

Summary
Parkinson's Disease (PD) is a complex neurodegenerative disorder impacting millions worldwide, presenting in sporadic forms as well as inherited. In all forms, the genetic variants play a role in influencing disease risk. About 100 genes have been linked to the susceptibility of PD, identified through familial and genome-wide association and prospectively through machine learning studies. Genetic variants associated with PD through GWASs are mostly located within intronic regions, whereas rare variants are mostly coding. Our hypothesis focuses on studying these coding regions within PD-related genes that encode specific protein domains. Through this analysis, we aim to identify which particular domains in these PD risk genes are functionally linked to the disease risk. Therefore, in our proposed research study, we aim to delve deeper into PD risk genes by conducting a per-domain rare-variant burden analysis of each PD risk gene. To conduct our analysis on the list of genes, we will utilize genetic data from our local cohorts along with the data from UK Biobank and AMP-PD with the total of ~10,000 PD patients and ~500,000 controls. We will demarcate the domains in each gene and apply burden analysis using optimized Sequence Kernel Association Test (SKAT-O) to study association of rare variants with PD. By categorizing variants according to functional domains in our per-domain analysis, we reduce the statistical cancelling effect that variants within protective domains may have on variants of risk-inducing domains, improving likelihood for statistical significance. In our results, we expect to find PD risk associations for specific functional domains, which would ultimately help us better understand PD pathogenesis and find novel targets for drug development
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
506511
Name
Parlar Sitki C
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Analysis of Next Generation Sequencing Data for Rare Variant Burden in Parkinson's Disease and Per-Domain Study of Parkinson's Risk Genes
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Burden Analysis; Genes; Human Genetics; Meta-Analysis; Neurogenetics; Next-Gen Sequencing; Parkinson’S Disease; Per Domain; Population Statistics; Rare Variant
Abstract
Parkinson's Disease (PD) is a complex neurodegenerative disorder impacting millions worldwide, presenting in sporadic forms as well as inherited. In all forms, the genetic variants play a role in influencing disease risk. About 100 genes have been linked to the susceptibility of PD, identified through familial and genome-wide association and prospectively through machine learning studies. Genetic variants associated with PD through GWASs are mostly located within intronic regions, whereas rare variants are mostly coding. Our hypothesis focuses on studying these coding regions within PD-related genes that encode specific protein domains. Through this analysis, we aim to identify which particular domains in these PD risk genes are functionally linked to the disease risk. Therefore, in our proposed research study, we aim to delve deeper into PD risk genes by conducting a per-domain rare-variant burden analysis of each PD risk gene. To conduct our analysis on the list of genes, we will utilize genetic data from our local cohorts along with the data from UK Biobank and AMP-PD with the total of ~10,000 PD patients and ~500,000 controls. We will demarcate the domains in each gene and apply burden analysis using optimized Sequence Kernel Association Test (SKAT-O) to study association of rare variants with PD. By categorizing variants according to functional domains in our per-domain analysis, we reduce the statistical cancelling effect that variants within protective domains may have on variants of risk-inducing domains, improving likelihood for statistical significance. In our results, we expect to find PD risk associations for specific functional domains, which would ultimately help us better understand PD pathogenesis and find novel targets for drug development
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Parlar, Sitki C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~